Singapore: Daiichi Sankyo is expanding its use of US-based Medidata Solutions' cloud-based platform to support clinical ...
Singapore: Daiichi Sankyo and Amplimmune have entered into a strategic collaboration to develop a new therapeutic prote...
Singapore: The independent Data Monitoring Committee (DMC) of the phase III MARQUEE (Met inhibitor ARQ 197 plus Erlotin...
Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into a...
Singapore: Mylan Specialty, a subsidiary of Mylan, and Pfizer entered into a license agreement, under which Pfizer will ...
Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement ...
Singapore: Stroke, the destruction of brain tissue from blockage or rupture of blood vessels, is one of the leading caus...
Singapore: Japanese pharmaceutical company Eisai has said that it will soon begin therapeutic testing of a drug that it ...
Singapore: Eisai has expressed strong disappointment with Institute for Quality and Efficiency in Health Care (IQWiG), G...
Singapore: Japanese firm Ono Pharmaceutical and BioFocus, a service division of Galapagos and based in the UK, have sign...
Singapore: Sosei has successfully completed a Japanese phase I trial for SO-1105 for the treatment of oropharyngeal cand...
Singapore: Updated results from a phase II study of orteronel, a selective oral 17,20 lyase inhibitor, dosed without pre...
Singapore: Takeda Pharmaceutical and Pfizer Japan have concluded an agreement that, as of December 31, 2012, Takeda will...
Singapore: The GBI Research has revealed that the non-small cell lung cancer (NSCLC) therapeutics market value in the As...
Singapore: Daiichi Sankyo has been approved for the Japanese Ministry of Economy, Trade and Industry's production facili...
Singapore: Kyowa Hakko Kirin has agreed to return development and marketing rights of Busulfex, for use as a part of con...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Leading biopharmaceutical company Aegerion Pharmaceuticals that is dedicated to the development and commercia...
Not long ago, it was one of India's iconic companies. Ranbaxy, which is now a subsidiary of Japanese giant Daiichi Sanky...
Singapore: Korea-based Celltrion has completed filing procedure of biosimilar drug Remsima to obtain Japan's Ministry of...
Singapore: Japanese pharmaceutical major Takeda has been ordered by a US Federal court to pay $6 billion in punitive dam...
Singapore: Cellectricon has expanded its sales and service network into Asia through a distribution agreement for its D...
Singapore: Japanese drug major Mitsubishi Tanabe Pharma has announced that one of its subsidiaries, Tianjin Tanabe Seiya...
Singapore: Scientists at Kyoto University, Japan, have discovered the 'reset button' in the brain, which could be used t...
Singapore: Takeda Global Research & Development Center resubmitted New Drug Applications (NDAs) to the US FDA for al...
